Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners
- PMID: 17882694
- DOI: 10.1080/02699200701538181
Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners
Abstract
The prosodic aspects of hypokinetic dysarthria in Parkinson's disease (PD) have been the focus of numerous reports. Few data on the effects of levodopa on prosody, more specifically on the effects on the variability of prosodic characteristics such as pitch, loudness and speech rate, are available in advanced PD. The relation between these characteristics and comprehensibility is currently unknown. These topics are the focus of the present report. Ten patients with advanced PD were evaluated, with and without medication, by four speech-language pathologists during a reading task. A significant improvement of variability in pitch and loudness was demonstrated after medication intake. Comprehensibility improved following medication administration. Results are compared with previous studies.
Similar articles
-
The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease.Clin Neurol Neurosurg. 2007 Jul;109(6):495-500. doi: 10.1016/j.clineuro.2007.04.003. Epub 2007 May 16. Clin Neurol Neurosurg. 2007. PMID: 17509751
-
The effects of levodopa on word intelligibility in Parkinson's disease.J Commun Disord. 2005 May-Jun;38(3):187-96. doi: 10.1016/j.jcomdis.2004.09.001. Epub 2004 Nov 10. J Commun Disord. 2005. PMID: 15748723
-
Levodopa-induced alterations in speech rate in advanced Parkinson's disease.Acta Neurol Belg. 2006 Mar;106(1):19-22. Acta Neurol Belg. 2006. PMID: 16776432
-
[Speech and voice disorders in Parkinson's disease].Rev Neurol. 2010 Nov 1;51(9):542-50. Rev Neurol. 2010. PMID: 20979034 Review. Spanish.
-
[Dysarthria across Parkinson's disease progression. Natural history of its components: dysphonia, dysprosody and dysarthria].Rev Neurol (Paris). 2010 Oct;166(10):800-10. doi: 10.1016/j.neurol.2010.07.005. Epub 2010 Aug 26. Rev Neurol (Paris). 2010. PMID: 20800250 Review. French.
Cited by
-
Speech Characteristics of Patients with Parkinson's Disease-Does Dopaminergic Medications Have a Role?J Neurosci Rural Pract. 2021 Sep 22;12(4):673-679. doi: 10.1055/s-0041-1735249. eCollection 2021 Oct. J Neurosci Rural Pract. 2021. PMID: 34737501 Free PMC article.
-
Research-based Updates in Swallowing and Communication Dysfunction in Parkinson Disease: Implications for Evaluation and Management.Perspect ASHA Spec Interest Groups. 2019 Oct;4(5):825-841. doi: 10.1044/2019_pers-sig3-2019-0001. Epub 2019 Oct 11. Perspect ASHA Spec Interest Groups. 2019. PMID: 32104723 Free PMC article.
-
Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance-correlation analysis.Hum Brain Mapp. 2010 Feb;31(2):222-36. doi: 10.1002/hbm.20859. Hum Brain Mapp. 2010. PMID: 19639554 Free PMC article.
-
Relationships among rat ultrasonic vocalizations, behavioral measures of striatal dopamine loss, and striatal tyrosine hydroxylase immunoreactivity at acute and chronic time points following unilateral 6-hydroxydopamine-induced dopamine depletion.Behav Brain Res. 2015 Sep 15;291:361-371. doi: 10.1016/j.bbr.2015.05.042. Epub 2015 May 27. Behav Brain Res. 2015. PMID: 26026785 Free PMC article.
-
Modification of spectral features by nonhuman primates.Behav Brain Sci. 2014 Dec;37(6):574-6; discussion 577-604. doi: 10.1017/S0140525X13004226. Behav Brain Sci. 2014. PMID: 25514964 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical